DuPont's diversified turnover up 9%:
This article was originally published in Clinica
Executive Summary
US conglomerate DuPont has reported 9% growth in revenues for its diversified businesses to $3,339 million in the first half of the year. This division includes DuPont's imaging and diagnostics operations which were put up for sale in May (see Clinica No 656, p 11). Dupont's total first-half sales increased 12% to $21,578 million and net income rose 32% to $1,897 million.